Events

EIT education and skills days
OCT
Wed
15
OCT
Thu
16

Starts in 1 month from now

Location

Brussels

The Royal Museums of Fine Arts of Belgium, Regentschapsstraat 3, 1000 Brussel
Programmes
EIT Advanced Digital Skills

The European Institute of Innovation and Technology (EIT) tries to cross the bridge from innovation to business by helping promising start-ups. The crucial element of each success story is the human capital, especially in deep tech sectors where upskilling the labour force is a necessary requirement. 

To this purpose, the EIT will organise the Education and Skills days on the 15th and 16th of October in Brussels. This event will spotlight four of the EIT’s flagship education initiatives:

  • EIT Higher Education Initiative
  • EIT Deep Tech Talent Initiative
  • Girls Go Circular
  • EIT skills academies

This is an ideal opportunity for organisations that offer specialised trainings or advanced masters. You can find the full programme and details on this website

 

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.